James Healy - Insider Trading & Ownership

Location
3000 Sand Hill Road, 4 250, Menlo Park, CA
Summary
The estimated net worth of James Healy is at least $294M dollars as of September 18, 2025. James Healy is the Director of Natera, Inc. and owns shares of Natera, Inc. (NTRA) stock worth about $226M. James Healy is the Director of BioAge Labs, Inc. and owns shares of BioAge Labs, Inc. (BIOA) stock worth about $41.5M. James Healy is the Director of Rapport Therapeutics, Inc. and owns shares of Rapport Therapeutics, Inc. (RAPP) stock worth about $19.9M. James Healy is the Director of ArriVent Biopharma, Inc. and owns shares of ArriVent BioPharma, Inc. (AVBP) stock worth about $6.19M. James Healy is the Director of Coherus BioSciences, Inc. and owns shares of Coherus BioSciences, Inc. (CHRS) stock worth about $171K.
Signature
/s/ John LaRocca, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of James Healy

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NTRA Natera, Inc. Director $226M Apr 25, 2025
BIOA BioAge Labs, Inc. Director $41.5M Jun 5, 2025
RAPP Rapport Therapeutics, Inc. Director $19.9M Jun 17, 2025
AVBP ArriVent BioPharma, Inc. Director $6.19M Jan 30, 2024
CHRS Coherus BioSciences, Inc. Director $171K Jan 7, 2022
KRTX Karuna Therapeutics, Inc. Director $0 Mar 18, 2024
YMAB Y-mAbs Therapeutics, Inc. Director $0 Sep 16, 2025
BOLT Bolt Biotherapeutics, Inc. Director Jun 12, 2024
CINC CinCor Pharma, Inc. Director, 10%+ Owner Nov 28, 2022

Insider Transactions Reported by James Healy:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.